2RZ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Poseida Therapeutics Inc

Watchlist Manager

Watchlist

Price: 9.05 EUR Market Closed

Market Cap: €877.5m

	Poseida Therapeutics Inc F:2RZ	US
M	Microstrategy Inc F:MIGA	US
	Suncor Energy Inc TSX:SU	CA
S	Sarepta Therapeutics Inc SWB:AB3A	US
A	Agios Pharmaceuticals Inc F:8AP	US
	Taiheiyo Cement Corp TSE:5233	JP
T	Titan Machinery Inc F:3TY	US
	Cidara Therapeutics Inc F:20D0	US
L	Lagardere SA XBER:LAG	FR
	LVMH Moet Hennessy Louis Vuitton SE F:MOH	FR

Profitability Summary

Poseida Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-41%

Negative 3Y Average Operating Margin

-135%

Declining Operating Margin

-18% > -41%

Negative Net Margin

-40%

Negative 3Y Average Net Margin

-129%

Declining Net Margin

-19% > -40%

Negative Free Cash Flow Margin

-11%

Negative 3Y Average Free Cash Flow Margin

-63%

Declining Free Cash Flow Margin

-7% > -11%

Negative ROE

-58%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-151%

Declining ROIC

-47% > -106%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.